These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37763292)

  • 1. Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy.
    Russo V; Falco L; Tessitore V; Mauriello A; Catapano D; Napolitano N; Tariq M; Caturano A; Ciccarelli G; D'Andrea A; Giordano A
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
    Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
    J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
    O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
    Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis.
    Al-Samkari H; Connors JM
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30111746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cancer associated thrombosis: Which role for direct oral anticoagulants in 2018?].
    Frère C; Farge D
    J Med Vasc; 2018 Sep; 43(5):293-301. PubMed ID: 30217343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment modalities in cancer-associated venous thromboembolism (VTE).
    Soto Alsar J; Gutiérrez Ortiz de la Tabla A; Ortega Morán L; Muñoz Martín AJ
    Best Pract Res Clin Haematol; 2022 Mar; 35(1):101354. PubMed ID: 36030074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence].
    Gulizia Chairperson MM; Parrini Co-Chairperson I; Colivicchi Co-Chairperson F; Bisceglia I; Caiazza F; Gensini GF; Mureddu GF; Santomauro M; Ageno W; Ambrosetti M; Aspromonte N; Barni S; Bellocci F; Caldarola P; Carletti M; De Luca L; Di Fusco SA; Di Lenarda A; Di Nisio M; Domenicucci S; Enea I; Francese GM; Lestuzzi C; Lucà F; Maurea N; Nassiacos D; Pedretti RFE; Pusineri E; Roscio G; Rossini R; Russo A; Volterrani M; Gabrielli Co-Chairperson D
    G Ital Cardiol (Rome); 2020 Sep; 21(9):687-738. PubMed ID: 33094745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer.
    Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T
    J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis.
    Patel T; Nadeem T; Shahbaz U; Tanveer F; Ahsan M; Saeed U; Ahmed A; Kumar V; Ibne Ali Jaffari SM; Zaman MU; Kumar S; Khatri M; Varrassi G; Vanga P
    Cureus; 2023 Jun; 15(6):e41071. PubMed ID: 37519604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World.
    Hara N; Lee T; Nozato T; Terui Matsuyama M; Okata S; Nagase M; Mitsui K; Nitta G; Watanabe K; Miyazaki R; Nagamine S; Kaneko M; Nakamura T; Nagata Y; Miyamoto T; Obayashi T; Ashikaga T
    Circ J; 2022 May; 86(6):923-933. PubMed ID: 34645732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies.
    Guan T; Laguna A; Soares A; Legasto CS; Block S; Saunders IM; Alvarez K; Pon T; Patel N; Mahajan A; Lee A
    J Thromb Thrombolysis; 2023 Oct; 56(3):439-446. PubMed ID: 37421494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
    Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
    Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis.
    Yan YD; Ding Z; Pan MM; Xia Q; Cui JJ; Wang LW; Zhang C; Gu ZC
    Front Cardiovasc Med; 2020; 7():586020. PubMed ID: 33304929
    [No Abstract]   [Full Text] [Related]  

  • 18. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of DVT: how long is enough and how do you predict recurrence.
    Agnelli G; Becattini C
    J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.